Delaware
|
001-34045
|
54-1887631
|
(State
or other jurisdiction
|
(Commission
|
(I.R.S.
Employer
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
(d)
|
Exhibits
|
|
99.1
|
Colfax
Corporation press release dated February 15, 2011, reporting
financial results for the fourth quarter and year ended December 31,
2010.
|
|
99.2
|
Colfax
Corporation slides for February 15, 2011 conference call reporting
financial results for the fourth quarter and year ended December 31,
2010.
|
Colfax
Corporation
|
|||
Date: February 15,
2011
|
By:
|
/s/ CLAY
H. KIEFABER
|
|
Name:
|
Clay
H. Kiefaber
|
||
Title:
|
President
and Chief Executive
Officer
|
99.1
|
Colfax
Corporation press release dated February 15, 2011,
reporting financial results for the fourth quarter and year
ended December 31, 2010.
|
99.2
|
Colfax
Corporation slides for February 15, 2010 conference call
reporting financial results for the fourth quarter and year ended
December 31, 2010.
|
Colfax Reports Fourth Quarter and Full Year 2010 Results and Announces Acquisition of Rosscor Holding B.V.
FULTON, Md., Feb. 15, 2011 /PRNewswire/ -- Colfax Corporation (NYSE: CFX), a global leader in fluid-handling solutions for critical applications, today announced financial results for the fourth quarter and year ended December 31, 2010. On a year-over-year basis, highlights for the fourth quarter and full year of 2010 include:
Fourth quarter of 2010 (all comparisons versus the fourth quarter of 2009)
Full year 2010 (all comparisons versus full year 2009)
Additionally, Colfax announced the acquisition of Rosscor Holding B.V., headquartered in Hengelo, The Netherlands. A premier supplier of multiphase pumping technology (MPP) and certain other highly-engineered fluid-handling systems, Rosscor strengthens Colfax's capabilities, particularly in the global oil & gas market. Rosscor's sales for 2010 were approximately euro 23 million. Colfax expects the transaction to be accretive over the next 12 months.
Adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth and organic order growth are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP"). See below for a description of the measures' usefulness and a reconciliation of these measures to their most directly comparable GAAP financial measures.
Clay Kiefaber, President and Chief Executive Officer, stated, "We are pleased to report stronger than expected results for the fourth quarter and full year 2010. Both sales and orders on an organic basis were up substantially from the 2009 fourth quarter. We continue to benefit from strength in the oil and gas and general industrial end markets. The commercial marine market also continued to exceed our expectations. We are also pleased with the resulting profit associated with the better than expected sales and the significant cash flow provided by our improved working capital management.
"We are continuing to gain traction with our strategic priorities, including intensifying the application of the Colfax Business System, the development of new Voice of the Customer-aligned products and the realignment into a global market-facing organization. We are also continuing to build our leadership team, and are delighted to welcome Daniel A. Pryor as our Senior Vice President of Strategy and Business Development."
Mr. Kiefaber also noted the importance of Rosscor's MPP expertise and experience to Colfax's portfolio of leading global brands. "Rosscor was one of the first to introduce MPP technology nearly twenty years ago, and has remained a technology leader since then," he said. "With more than 70 MPP installations world-wide, Rosscor brings us deep capabilities in MPP that we can leverage through our existing channels."
Non-GAAP Financial Measures and Other Adjustments
Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, earnings before interest, taxes and depreciation (EBITDA), adjusted EBITDA, organic sales growth, organic order growth and projected adjusted net income per share. Adjusted net income, adjusted net income per share, adjusted EBITDA and adjusted operating income exclude asbestos liability and defense costs (income) and asbestos coverage litigation expenses, and restructuring and other related charges to the extent they impact the periods presented. Adjusted net income, adjusted net income per share and projected adjusted net income per share present income taxes at an effective tax rate of 32%. Projected adjusted net income per share excludes estimated restructuring and other related charges, asbestos coverage litigation expenses and asbestos liability and defense costs. Organic sales growth and organic order growth exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of legacy asbestos issues and items outside the control of its operating management team.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release
Colfax defines net working capital as trade receivables, less allowance for doubtful accounts, and inventories, net less accounts payable.
Conference Call and Webcast
Colfax will host a conference call to provide details about its results and outlook on Tuesday, February 15, 2011 at 8:00 a.m. ET. The call will be open to the public through 877-303-7908 or 678-373-0875 and webcast via Colfax's website at www.colfaxcorp.com under the "Investor Relations" section. Access to a supplemental slide presentation can also be found at the Colfax website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.
About Colfax Corporation
Colfax Corporation is a global leader in critical fluid-handling products and technologies. Through its global operating subsidiaries, Colfax manufactures positive displacement industrial pumps and valves used in oil & gas, power generation, commercial marine, defense and general industrial markets. Colfax's operating subsidiaries supply products under the well-known brands Allweiler, Baric, Fairmount Automation, Houttuin, Imo, LSC, Portland Valve, Tushaco, Warren and Zenith. Colfax is traded on the NYSE under the ticker "CFX." Additional information about Colfax is available at www.colfaxcorp.com.
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on Colfax's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax's results to differ materially from current expectations include, but are not limited to factors detailed in Colfax's reports filed with the U.S. Securities and Exchange Commission as well as its Annual Report on Form 10-K under the caption "Risk Factors". In addition, these statements are based on a number of assumptions that are subject to change. This press release speaks only as of this date. Colfax disclaims any duty to update the information herein.
The term "Colfax" in reference to the activities described in this press release may mean one or more of Colfax's global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.
Colfax Corporation | |||||||||
Condensed Consolidated Statements of Operations | |||||||||
Dollars in thousands, except per share data | |||||||||
(Unaudited) | |||||||||
|
|
|
|
|
|
|
|
| |
|
| Three Months Ended December 31, |
| Year Ended December 31, | |||||
|
| 2010 |
| 2009 |
| 2010 |
| 2009 | |
|
|
|
|
|
|
|
|
| |
Net sales |
| $166,651 |
| $130,971 |
| $541,987 |
| $525,024 | |
Cost of sales |
| 107,077 |
| 83,960 |
| 350,579 |
| 339,237 | |
|
|
|
|
|
|
|
|
| |
Gross profit |
| 59,574 |
| 47,011 |
| 191,408 |
| 185,787 | |
Selling, general and administrative expenses |
| 31,597 |
| 27,028 |
| 119,426 |
| 112,503 | |
Research and development expenses |
| 1,474 |
| 1,320 |
| 6,205 |
| 5,930 | |
Restructuring and other related charges |
| 808 |
| 7,420 |
| 10,323 |
| 18,175 | |
Asbestos liability and defense costs (income) |
| 3,697 |
| (1,017) |
| 7,876 |
| (2,193) | |
Asbestos coverage litigation expenses |
| 2,443 |
| 2,904 |
| 13,206 |
| 11,742 | |
|
|
|
|
|
|
|
|
| |
Operating income |
| 19,555 |
| 9,356 |
| 34,372 |
| 39,630 | |
Interest expense |
| 1,609 |
| 1,746 |
| 6,684 |
| 7,212 | |
|
|
|
|
|
|
|
|
| |
Income before income taxes |
| 17,946 |
| 7,610 |
| 27,688 |
| 32,418 | |
Provision for income taxes |
| 9,296 |
| 884 |
| 11,473 |
| 8,621 | |
|
|
|
|
|
|
|
|
| |
Net income |
| $ 8,650 |
| $ 6,726 |
| $ 16,215 |
| $ 23,797 | |
|
|
|
|
|
|
|
|
| |
Net income per share—basic |
| $ 0.20 |
| $ 0.16 |
| $ 0.37 |
| $ 0.55 | |
|
|
|
|
|
|
|
|
| |
Net income per share—diluted |
| $ 0.20 |
| $ 0.15 |
| $ 0.37 |
| $ 0.55 | |
Colfax Corporation | ||||||
Condensed Consolidated Balance Sheets | ||||||
Dollars in thousands | ||||||
(Unaudited) | ||||||
|
|
|
|
|
| |
|
|
| December 31, | |||
|
|
| 2010 |
| 2009 | |
|
|
|
|
|
| |
ASSETS |
|
|
|
| ||
CURRENT ASSETS: |
|
|
|
| ||
| Cash and cash equivalents |
| $ 60,542 |
| $ 49,963 | |
| Trade receivables, less allowance for doubtful accounts |
| 98,070 |
| 88,493 | |
| Inventories, net |
| 57,941 |
| 71,150 | |
| Asbestos insurance asset |
| 34,117 |
| 31,502 | |
| Asbestos insurance receivable |
| 46,108 |
| 35,891 | |
| Other current assets |
| 24,278 |
| 20,649 | |
|
|
|
|
|
| |
Total current assets |
| 321,056 |
| 297,648 | ||
Deferred income taxes, net |
| 52,385 |
| 51,838 | ||
Property, plant and equipment, net |
| 89,246 |
| 92,090 | ||
Goodwill and intangible assets, net |
| 200,636 |
| 175,370 | ||
Long-term asbestos insurance asset |
| 340,234 |
| 357,947 | ||
Long-term asbestos insurance receivable |
| 5,736 |
| 16,876 | ||
Deferred loan costs and other assets |
| 12,784 |
| 14,532 | ||
Total assets |
| $ 1,022,077 |
| $ 1,006,301 | ||
|
|
|
|
|
| |
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
| ||
CURRENT LIABILITIES: |
|
|
|
| ||
| Current portion of long-term debt and capital leases |
| $ 10,000 |
| $ 8,969 | |
| Accounts payable |
| 50,896 |
| 36,579 | |
| Accrued asbestos liability |
| 37,875 |
| 34,866 | |
| Other accrued liabilities |
| 92,739 |
| 70,685 | |
|
|
|
|
|
| |
Total current liabilities |
| 191,510 |
| 151,099 | ||
Long-term debt, less current portion |
| 72,500 |
| 82,516 | ||
Long-term asbestos liability |
| 391,776 |
| 408,903 | ||
Pension and accrued post-retirement benefits |
| 112,257 |
| 105,230 | ||
Other liabilities |
| 37,663 |
| 41,728 | ||
Total liabilities |
| 805,706 |
| 789,476 | ||
Shareholder's equity |
| 216,371 |
| 216,825 | ||
Total liabilities and shareholders' equity |
| $ 1,022,077 |
| $ 1,006,301 | ||
Colfax Corporation | |||||
Condensed Consolidated Statement of Cash Flows | |||||
Dollars in thousands | |||||
(Unaudited) | |||||
|
|
|
|
| |
|
| Year ended December 31, | |||
|
| 2010 |
| 2009 | |
Cash flows from operating activities: |
|
|
|
| |
Net income |
| $ 16,215 |
| $ 23,797 | |
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
| |
Depreciation, amortization and fixed asset impairment charges |
| 16,130 |
| 15,074 | |
Noncash stock-based compensation |
| 3,137 |
| 2,593 | |
Other adjustments for non-cash items |
| 767 |
| 613 | |
Deferred income taxes |
| (296) |
| 2,689 | |
Changes in working capital |
| 27,297 |
| 6,144 | |
Changes in other operating assets and liabilities |
| (1,285) |
| (12,206) | |
Net cash provided by operating activities |
| 61,965 |
| 38,704 | |
|
|
|
|
| |
Cash flows from investing activities: |
|
|
|
| |
Purchases of fixed assets |
| (12,527) |
| (11,006) | |
Acquisitions, net of cash received |
| (27,960) |
| (1,678) | |
Proceeds from sale of fixed assets |
| 74 |
| 219 | |
Net cash used in investing activities |
| (40,413) |
| (12,465) | |
|
|
|
|
| |
Cash flows from financing activities: |
|
|
|
| |
Payments under term credit facility |
| (8,750) |
| (5,000) | |
Proceeds from borrowings on revolving credit facilities |
| 5,500 |
| - | |
Repayments of borrowings on revolving credit facilities |
| (5,500) |
| - | |
Other |
| 707 |
| (417) | |
Net cash used in financing activities |
| (8,043) |
| (5,417) | |
|
|
|
|
| |
Effect of exchange rates on cash |
| (2,930) |
| 379 | |
|
|
|
|
| |
Increase in cash and cash equivalents |
| 10,579 |
| 21,201 | |
Cash and cash equivalents, beginning of year |
| 49,963 |
| 28,762 | |
Cash and cash equivalents, end of year |
| $ 60,542 |
| $ 49,963 | |
Colfax Corporation | |||||||||
Reconciliation of GAAP to non-GAAP Financial Measures | |||||||||
Dollars in thousands, except share data | |||||||||
(Unaudited) | |||||||||
| |||||||||
|
| Three Months Ended
|
| Year Ended
| |||||
|
| 2010 |
| 2009 |
| 2010 |
| 2009 | |
|
|
|
|
|
|
|
|
| |
EBITDA |
|
|
|
|
|
|
|
| |
Net income |
| $ 8,650 |
| $ 6,726 |
| $ 16,215 |
| $ 23,797 | |
|
|
|
|
|
|
|
|
| |
Interest expense |
| 1,609 |
| 1,746 |
| 6,684 |
| 7,212 | |
Provision for income taxes |
| 9,296 |
| 884 |
| 11,473 |
| 8,621 | |
Depreciation and amortization |
| 4,888 |
| 3,834 |
| 16,130 |
| 14,426 | |
|
|
|
|
|
|
|
|
| |
EBITDA |
| $ 24,443 |
| $ 13,190 |
| $ 50,502 |
| $ 54,056 | |
EBITDA margin |
| 14.7% |
| 10.1% |
| 9.3% |
| 10.3% | |
|
|
|
|
|
|
|
|
| |
Adjusted EBITDA |
|
|
|
|
|
|
|
| |
Net income |
| $ 8,650 |
| $ 6,726 |
| $ 16,215 |
| $ 23,797 | |
|
|
|
|
|
|
|
|
| |
Interest expense |
| 1,609 |
| 1,746 |
| 6,684 |
| 7,212 | |
Provision for income taxes |
| 9,296 |
| 884 |
| 11,473 |
| 8,621 | |
Depreciation and amortization |
| 4,888 |
| 3,834 |
| 16,130 |
| 14,426 | |
Restructuring and other related charges |
| 808 |
| 7,420 |
| 10,323 |
| 18,175 | |
Asbestos liability and defense costs (income) |
| 3,697 |
| (1,017) |
| 7,876 |
| (2,193) | |
Asbestos coverage litigation expenses |
| 2,443 |
| 2,904 |
| 13,206 |
| 11,742 | |
|
|
|
|
|
|
|
|
| |
Adjusted EBITDA |
| $ 31,391 |
| $ 22,497 |
| $ 81,907 |
| $ 81,780 | |
Adjusted EBITDA margin |
| 18.8% |
| 17.2% |
| 15.1% |
| 15.6% | |
|
|
|
|
|
|
|
|
| |
Adjusted Net Income and Adjusted Earnings per Share |
|
|
|
|
|
|
|
| |
Net income |
| $ 8,650 |
| $ 6,726 |
| $ 16,215 |
| $ 23,797 | |
|
|
|
|
|
|
|
|
| |
Restructuring and other related charges |
| 808 |
| 7,420 |
| 10,323 |
| 18,175 | |
Asbestos liability and defense costs (income) |
| 3,697 |
| (1,017) |
| 7,876 |
| (2,193) | |
Asbestos coverage litigation expenses |
| 2,443 |
| 2,904 |
| 13,206 |
| 11,742 | |
Tax adjustment to effective rate of 32% |
| 1,330 |
| (4,529) |
| (7,437) |
| (10,624) | |
|
|
|
|
|
|
|
|
| |
Adjusted net income |
| $ 16,928 |
| $ 11,504 |
| $ 40,183 |
| $ 40,897 | |
Adjusted net income margin |
| 10.2% |
| 8.8% |
| 7.4% |
| 7.8% | |
|
|
|
|
|
|
|
|
| |
Weighted average shares outstanding - diluted |
| 43,876,791 |
| 43,449,493 |
| 43,667,225 |
| 43,325,704 | |
Adjusted net income per share |
| $ 0.39 |
| $ 0.26 |
| $ 0.92 |
| $ 0.94 | |
|
|
|
|
|
|
|
|
| |
Net income per share—diluted |
|
|
|
|
|
|
|
| |
in accordance with GAAP |
| $ 0.20 |
| $ 0.15 |
| $ 0.37 |
| $ 0.55 | |
|
|
|
|
|
|
|
|
| |
Adjusted Operating Income |
|
|
|
|
|
|
|
| |
Operating income |
| $ 19,555 |
| $ 9,356 |
| $ 34,372 |
| $ 39,630 | |
|
|
|
|
|
|
|
|
| |
Restructuring and other related charges |
| 808 |
| 7,420 |
| 10,323 |
| 18,175 | |
Asbestos liability and defense costs (income) |
| 3,697 |
| (1,017) |
| 7,876 |
| (2,193) | |
Asbestos coverage litigation expenses |
| 2,443 |
| 2,904 |
| 13,206 |
| 11,742 | |
|
|
|
|
|
|
|
|
| |
Adjusted operating income |
| $ 26,503 |
| $ 18,663 |
| $ 65,777 |
| $ 67,354 | |
Adjusted operating income margin |
| 15.9% |
| 14.2% |
| 12.1% |
| 12.8% | |
|
|
|
|
|
|
|
|
| |
Colfax Corporation | |||||||||
Change in Sales and Orders | |||||||||
Dollars in millions | |||||||||
(Unaudited) | |||||||||
|
|
|
|
|
|
|
|
| |
| Sales |
| Orders |
|
|
| |||
$ | % |
| $ | % |
|
|
| ||
|
|
|
|
|
|
|
|
| |
Three Months Ended December 31, 2009 | $ 131.0 |
|
| $ 101.6 |
|
|
|
| |
|
|
|
|
|
|
|
|
| |
Components of Change: |
|
|
|
|
|
|
|
| |
Existing Businesses | 36.0 | 27.4 % |
| 35.0 | 34.4 % |
|
|
| |
Acquisitions | 5.4 | 4.1 % |
| 1.3 | 1.3 % |
|
|
| |
Foreign Currency Translation | (5.7) | (4.3)% |
| (4.3) | (4.2)% |
|
|
| |
|
|
|
|
|
|
|
|
| |
Total | 35.7 | 27.2 % |
| 32.0 | 31.5 % |
|
|
| |
|
|
|
|
|
|
|
|
| |
Three Months Ended December 31, 2010 | $ 166.7 |
|
| $ 133.6 |
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
| Sales |
| Orders |
| Backlog at
| ||||
$ | % |
| $ | % |
| $ | % | ||
|
|
|
|
|
|
|
|
| |
Year ended December 31, 2009 | $ 525.0 |
|
| $ 462.4 |
|
| $ 290.9 |
| |
|
|
|
|
|
|
|
|
| |
Components of Change: |
|
|
|
|
|
|
|
| |
Existing Businesses | 16.1 | 3.1 % |
| 71.1 | 15.4 % |
| (6.6) | (2.3)% | |
Acquisitions | 10.0 | 1.9 % |
| 6.1 | 1.3 % |
| 38.7 | 13.3 % | |
Foreign Currency Translation | (9.1) | (1.7)% |
| (6.8) | (1.5)% |
| (9.5) | (3.3)% | |
|
|
|
|
|
|
|
|
| |
Total | 17.0 | 3.2 % |
| 70.4 | 15.2 % |
| 22.6 | 7.8 % | |
|
|
|
|
|
|
|
|
| |
Year ended December 31, 2010 | $ 542.0 |
|
| $ 532.8 |
|
| $ 313.5 |
| |
CONTACT: Scott Brannan, Chief Financial Officer, Colfax Corporation, +1-301-323-9005, Scott.Brannan@colfaxcorp.com